-
On Dec. 22, 2010, the Food and Drug Administration approved a new 200 mg etravirine (Intelence®) tablet. Etravirine was originally approved in 2008, in only a 100 mg tablet formulation. The new 200 mg dosage form can help reduce pill burden for patients taking Intelence.
-
The National Newspaper Publishers Association (NNPA) has joined a cooperative effort using enhanced media coverage to re-engage African Americans in the fight against HIV/AIDS.
-
In this study, 2,499 hiv-seronegative men or transgender females who have sex with men (MSM) were randomized to daily TDF/FTC vs. placebo in a multicenter, controlled trial with clinical sites in North America, Latin America, Thailand, and Africa.
-
A long-time patient, who is a 56-year-old male, arrives for his annual exam complaining of excessive thirst, frequent urination, unplanned weight gain, and fatigue. His blood pressure, which was borderline hypertensive last year, is now 160/95. He reports no change in diet, job responsibilities, or family life. This year, you have added another screening to the standard vital signs.
-
-
A prospective study from November 2001 through October 2005 in Israel collected nasopharyngeal wash specimens from children < 5 years who were diagnosed with community-acquired alveolar pneumonia.
-
Recurrent urinary tract infections (UTI) in females is a common and distressing clinical problem.
-
These authors examined the use of antimicrobials for skin and soft tissue infection (SSTI), comparing the presentation, complications, microbial results and outcomes of adults hospitalized at Denver Health Medical Center.
-
In this issue: Rivaroxaban may be dabigatran's first competitor; a new way to measure non-adherence to medication therapy; FDA Actions.
-
In 1854, london was rocked by a cholera epidemic that killed approximately 10,000 people. Using what are now considered classical epidemiological methods, Dr. John Snow traced the source of at least 500 of the infections to a single water pump at Broad Street, validating his theory that cholera was a water-borne disease 29 years before the etiologic agent was discovered by Robert Koch; removing the pump handle stopped the outbreak in that area.
